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Abstract
Background: The fruit fly, Drosophila melanogaster, is a well-established model organism for probing the molecular and
cellular basis of physiological and immune system responses of adults or late stage larvae to bacterial challenge. However,
very little is known about the consequences of bacterial infections that occur in earlier stages of development. We have
infected mid-second instar larvae with strains of Pseudomonas fluorescens to determine how infection alters the ability of
larvae to survive and complete development.
Methodology/Principal Findings: We mimicked natural routes of infection using a non-invasive feeding procedure to study
the toxicity of the three sequenced P. fluorescens strains (Pf0-1, SBW25, and Pf-5) to Drosophila melanogaster. Larvae fed with
the three strains of P. fluorescens showed distinct differences in developmental trajectory and survival. Treatment with
SBW25 caused a subset of insects to die concomitant with a systemic melanization reaction at larval, pupal or adult stages.
Larvae fed with Pf-5 died in a dose-dependent manner with adult survivors showing eye and wing morphological defects. In
addition, larvae in the Pf-5 treatment groups showed a dose-dependent delay in the onset of metamorphosis relative to
control-, Pf0-1-, and SBW25-treated larvae. A functional gacA gene is required for the toxic properties of wild-type Pf-5
bacteria.
Conclusions/Significance: These experiments are the first to demonstrate that ingestion of P. fluorescens bacteria by D.
melanogaster larvae causes both lethal and non-lethal phenotypes, including delay in the onset of metamorphosis and
morphological defects in surviving adult flies, which can be decoupled.
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Introduction
The fruit fly, Drosophila melanogaster, is a well-established model
organism for the study of host response to microbial infection and
animal development. To protect against infection, D. melanogaster
employs a suite of cellular and humoral defense mechanisms,
making it a good reference organism in which to dissect host
responses (reviewed in [1,2,3,4,5,6]). For example, D. melanogaster
employ mechanical barriers (such as the cuticle and tightly
connected epithelial cells) to reduce the entry of environmental
pathogens. In addition, a rapid defense is mounted through the
secretion of a battery of inducible effector molecules (i.e.
antimicrobial peptides such as Diptericin and reactive oxygen
species), activation of phenoloxidase through a complement-like
protease cascade (which leads to the production of reactive
compounds and melanin), clotting of the hemolymph, and
phagocytosis and encapsulation of foreign objects by blood cells
(hemocytes), all of which are tightly regulated mechanisms for
neutralizing intruders while maintaining a balanced microbiota.
D. melanogaster larvae and adults are exposed to a variety of
environmental bacteria in their natural habitats. Among these are
species of Pseudomonas, a diverse genus of gamma proteobacteria
commonly found in soil, water, or in association with plants or
animals. Certain strains of Pseudomonas entomophila [7] and
Pseudomonas aeruginosa [8,9] are known pathogens of D. melanogaster,
but this pathogenicity is thought to be uncommon for the genus.
Of 28 strains representing a spectrum of Pseudomonas spp. that were
tested by Vodovar et al. [7], only P. entomophila exhibited
pathogenicity against D. melanogaster. Nevertheless, genes with
predicted functions in insect toxicity are present in genomic
sequences of other Pseudomonas spp., including fitD in Pseudomonas
fluorescens strains Pf-5 and CHA0 [10], and tc-like toxins in
Pseudomonas syringae pv. syringae strain B728a and P. fluorescens Pf0-1
[11]. A recent study demonstrated that fitD confers strong
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related strain CHA0 was injected into larvae of two insect species,
the tobacco hornfworm Manduca sexta and the greater wax moth
Galleria mellonella [10]. These results highlighted the exciting possibility
that strains of P. fluorescens have additional previously-unappreciated
insecticidal activities.
This study was initiated to determine the oral toxicity of P.
fluorescens against the model organism D. melanogaster, and to
characterize the effect of the microbial infection throughout host
development. The immune response to high doses of pathogenic
and non-pathogenic bacteria has been studied extensively in adult
D. melanogaster and late stage larvae. Very few experiments have
examined the impact of exposure to bacteria at earlier develop-
mental stages when the animals are undergoing rapid growth of
both body tissues and rapid divisions of the imaginal disc cells,
which will generate the adult body. We developed a new protocol
to feed timed cultures of D. melanogaster larvae with bacterial strains
without handling the larvae, hence reducing the risk of injuries and
stress prior to infection. Using this non-invasive protocol, we
observed three distinct and strain-specific responses of D.
melanogaster to infection by three strains of P. fluorescens (Pf0-1,
SBW25 and Pf-5) with fully sequenced genomes [12,13]. Oral
ingestion of strain Pf0-1 had little effect on larvae. In contrast,
strains SBW25 and Pf-5 were toxic to D. melanogaster, with SBW25
causing a systemic melanization response and Pf-5 causing a dose-
dependent lethality and delayed metamorphosis coupled with
morphological defects in adults. Induction of an immune response
after oral infection with Pf-5, SBW25 and Pf0-1 was also observed
by using a diptericin-lacZ reporter. Using the novel larval feeding
assay developed herein, we could assess the effect of bacterial
infection on larval growth rate, development of the imaginal discs
and timing of metamorphosis, thereby establishing the toxicity of
P. fluorescens SBW25 and Pf-5 to D. melanogaster and revealing
intriguing new insights into the coupled effects of microbial
infection on host defense response and development.
Results
Pf-5 and SBW25 reduced D. melanogaster survival
We determined the effect of three strains of P. fluorescens on
larval and pupal survival in a newly-developed, non-invasive
feeding assay (Fig. 1). Second instar CantonS-A (CS-A) wild-type
larvae were fed with a yeast suspension containing high cell
densities of bacteria or, as a control treatment, yeast suspension
containing no added bacterial cells. In the control treatments,
8664% of the larvae survived to become adults (Fig. 2, Fig. S1).
Similarly, 8761% of larvae fed with P. fluorescens strain Pf0-1 at
doses ranging from 10
3 to 10
9 cfu/plate survived to adulthood
(Fig. 2, Fig. S1), which is not different from the survival of larvae in
the control treatment group (X
2=0.95, Df=6, P=0.99). In
contrast, only 30610% of larvae fed with a yeast suspension
containing 10
7 or 10
9 cells of SBW25 survived to adulthood
(Fig. 2A, Fig. S1), which is significantly different from the control
treatment group (X
2=61.1, Df=1, P,0.00001). Insects in the
SBW25 treatment died at two different stages: approximately half
(5868%) of the larvae pupariated and, of those pupae, only about
half (49613%) emerged as adults. Thus, ingestion of SBW25 by
larvae caused individuals at both feeding and non-feeding stages to
die. The consequence of ingesting Pf-5 bacteria was more severe;
no larvae fed Pf-5 at the highest dose tested, 10
9 cfu/plate,
pupariated (Fig. 2, Fig. S1).
Other wild-type D. melanogaster strains also showed high
mortality after feeding with Pf-5 and SBW25 bacteria (Fig. S1;
data not shown). When larvae of the Oregon-R (OR) or other two
CS wild-type strains were fed Pf-5 at 10
7 cfu/plate, none
pupariated. At a lower dose of 10
4 cfu/plate, few OR or CS
larvae survived to adulthood (363% and 764%). OR larvae fed
SBW25 at either 10
4 or10
7 cfu/plate had reduced survival to
adulthood (Fig. S1). Thus, ingestion of strains Pf-5 and SBW25
significantly reduced larval and pupal survival rates of D.
melanogaster.
Figure 1. Timeline of the experimental protocol. Above the daily timeline are cartoons of the developmental stage that most closely replicates
the control-treatment group trajectory (see Material and Methods for details). On Day 22, eggs were transferred from the egglaying plates to non-
nutritive agar plates. The split image on Day 4 indicates the transition period between wandering larvae and prepupal stages around the onset of
metamorphosis. Treatments distributed on the agar surface on Day 0 (open arrow) were composed of a yeast suspension, which served as a food
source for the larvae, alone (control) or amended with bacterial inoculum. An additional yeast supplement (food) was added on Day 2 to all plates
(solid arrow) and every 2 days as long as feeding larvae were visible (dashed arrow). Using this method, larvae were never directly handled and the
only disturbance was the application of treatments or food to the surface of the plate. The plates were housed in an incubator on a 12L:12D cycle
initially at 25uC; on Day 2, the temperature was shifted to 22uC to slow down larval development.
doi:10.1371/journal.pone.0012504.g001
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Pf-5
After determining that ingestion of Pf-5 killed larvae, we
investigated factors contributing to this toxicity. We first tested
whether living Pf-5 cells were required for lethality by feeding
larvae heat-killed Pf-5 cells at a dose of 10
9 cfu/plate. Because
9161% of larvae survived to adulthood (Fig. 3, Fig. S1), similar to
the rate of survival in control and Pf0-1-treatment groups, we
conclude that the toxicity of Pf-5 to D. melanogaster larvae requires
intact live bacterial cells or a heat-labile molecule.
Because the GacS/GacA two component regulatory system
controls the production of virulence factors and secondary
metabolites in Pseudomonas spp. [14] including strain Pf-5
[15,16,17], and is required for virulence of P. entomophila against
D. melanogaster [7], we tested the toxicity of a Pf-5 gacA mutant.
Whereas 9061% of larvae pupariated, fewer survived to
adulthood (8163%) when fed a yeast suspension containing Pf-5
gacA mutant cells at a dose of 10
7 cfu/plate; only 3865% of larvae
fed the same dose of wild-type Pf-5 survived (Fig. 2B). Thus, GacA
had a major effect on the insect toxicity exhibited by Pf-5. The
frequency of adult survival of Pf-5 gacA-treated larvae (averaging
7166% for three different experiments at doses of 3:8|104,
1:9|107, and 2:3|107cfu/plate) was found to be significantly
lower compared to that of control larvae (X
2=7.91, Df=2,
P=0.02). Thus, we conclude that the lethality associated with
ingestion of Pf-5 bacteria by D. melanogaster larvae is largely
dependent on GacA-regulated functions, but there must also be
one or more Pf-5 components unrelated to GacA that also
contribute to this lethality.
Larval and pupal survival after Pf-5-treatment was dose-
dependent
Larval survival was strongly dependent on the initial cell density
of Pf-5 added to the diet. No larvae survived to later stages when
fed with a yeast suspension containing Pf-5 at 10
9cfu/plate, and
both the frequency of pupariation and survival to adulthood
increased as the dose of Pf-5 was reduced (Figs 2B, 3, Fig. S1). Chi-
squared analysis revealed that the adult survival of larvae fed low
doses of Pf-5 (2:9|102 to 2:0|104cfu/plate) was not significantly
different to that of larvae in the control group (8463%, X
2=2.08,
Df=4, P=0.71). At intermediate doses of Pf-5 (2:9|104 to
7:2|105 cfu/plate), there was a significant difference in adult
survival compared to the control treatment group (6266%,
X
2=66.95, Df=8, P,0.00001). This difference was the result of a
significant reduction in the number of pupae surviving to become
adults (Figs 2B, 3; X
2=37.89, Df=8, P,0.00001). For the larvae
exposed to high treatment doses of Pf-5 (1.7610
7 to 2.9610
9 cfu/
plate), adult survival was significantly reduced (1764%,
X
2=229.73, Df=4, P,0.00001) due to a reduction in both the
number of larvae that pupariated and pupae that survived to adult
emergence (X
2=118.2, Df=4, P,0.0000; X
2=21.1, Df=4,
P,0.00003, respectively). For larvae fed Pf-5 at 10
7cfu/plate,
Figure 2. Developmental time course after bacterial inoculation. The percentage of larvae that pupariated, counted as prepupae and/or
pupae (solid lines), or emerged as adults (dashed lines) were determined for two different experiments (A and B) in which second instar larvae were
fed with a yeast suspension having no bacteria (black) or amended with bacterial strains Pf0-1 (blue), SBW25 (green, Fig. 2A), Pf-5 (red), or a Pf-5 gacA
mutant (open red circle, Fig. 2B). On the timeline in this and Figure 3, the egg-laying period is denoted by the egg cartoon and the treatment by an
open arrow at Day 0. Bacterial treatment as cfu/plate: (A) Pf0-1, 5:7|109; SBW25, 5:2|109; Pf-5, 2:9|109, or (B) Pf0-1, 7:1|106; Pf-5 gacA mutant,
1:9|107; Pf-5 (squares), 1:9|107; Pf-5 (triangles), 3:3|104.
doi:10.1371/journal.pone.0012504.g002
Figure 3. Developmental time course after inoculation with
different doses of Pf-5. The percentage of larvae that pupariated,
counted as prepupae and/or pupae (solid lines), or emerged as adults
(dashed lines) after inoculation with Pf-5 (filled red symbols or star),
killed Pf-5 (killed 2:9|109 cfu/plate, gray circles) or control (black circles )
treatment were determined for each time point. The Pf-5 cell densities as
cfu/plate were 2:9|109 (circles), 2:9|107 (squares), 2:9|105 (dia-
monds), 2:9|104 (triangles), 2:9|102 (stars) cfu/plate.
doi:10.1371/journal.pone.0012504.g003
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0–38%, suggesting that slight differences in the timing of the
bacterial treatment have a larger effect at this high dose than at
lower doses. To examine the effect of developmental age, we
compared the survival of first and second instar larvae fed the
same doses of Pf-5. No first instar larvae fed Pf-5 at 10
4 or 10
6
survived to the pupal stage, whereas second instar larvae fed the
same doses were able to pupariate (data not shown). Therefore, Pf-
5 ingestion caused both larval and pupal mortality in a dose-
dependent fashion.
Larvae fed with a yeast suspension containing high doses of Pf-5
tended to die at an earlier stage of development than larvae fed
with lower doses. For example, when Pf-5 was added at 10
9cfu/
plate, many larvae died as second instars, some molted into third
instar larvae but none were able to pupariate. At doses of 10
4 to
10
7 cfu/plate, most larvae survived to become third instars but
many were unable to pupariate or died as pre-pupae. Pre-pupae
that did not continue development characteristically failed to evert
their anterior spiracles or progress beyond the mid-bubble stage
and so did not complete pupal ecdysis [18]. At lower doses of Pf-5
(10
2–10
3), most larvae pupariated and a few pupae died at later
stages of metamorphosis. We found similar survival rates when the
total treatment dose was divided into two equal applications on
Day 0 and 1 (data not shown) or was delivered as a single dose on
Day 0, suggesting that it is the population of bacterial cells that is
important, not the feeding regimen, for determining survival.
Thus, we have found a strong dose-dependent correlation of
survival after ingestion of Pf-5.
Pf-5, but not Pf0-1 or SBW25, causes developmental
delay
We noticed that larvae exposed to Pf-5 treatment frequently
failed to pupariate even when viable for many days, suggesting
that they were arrested or delayed in their development. In
addition, this delay in pupariation also appeared to be dose-
dependent. Therefore, we calculated the relative duration of the
larval stage for larvae fed different concentrations of Pf-5 (Fig. 4A).
Larvae fed Pf-5 at lower doses delayed metamorphosis for up to a
day, whereas larvae fed higher doses pupariated with up to a
three-day delay. In experiments with high doses of Pf-5 ($10
7 cfu/
plate), some larvae survived for days but were frequently unable to
pupariate. In contrast, the duration of the pupal stage for most Pf-
5 treatment groups was similar to that of controls (i.e within a half
day), indicating that there is no systematic developmental delay
during this stage (Fig. 4B). Thus, as shown in Figure 4C, the
overall delay to adult emergence for Pf-5 treatments reflects the
delay in pupariation and is accompanied by a reduction in the
number of pupae able to eclose as adults. Larvae of other D.
melanogaster wild-type strains exposed to Pf-5 bacterial treatments
also had delayed pupariation. When OR larvae were fed with
4.5610
4 cfu/plate Pf-5, pupariation was delayed for three days
(Fig. 4A). Larvae from two other CS strains also showed a delay in
pupariation (data not shown). The extended, dose-dependent
developmental delay is specific to the Pf-5 treatment; larvae fed
high doses of SBW25, killed Pf-5, or the Pf-5 gacA mutant cells
pupariated and emerged as adults at a similar time as control
larvae (Fig. 4). Only those CS-A larvae fed the highest dose of Pf0-
1 (10
9 cfu/plate) exhibited any delay in pupariation, and that delay
was very slight, whereas larvae fed with lower doses of Pf0-1
pupariated at the same time as control treated larvae (Fig. 4A).
Figure 4. Dose-dependent effects of P. fluorescens strains on
survival and developmental delay. For each experimental treat-
ment, the percent pupal or adult survival is normalized to that of the
appropriate control, which has been set to 100%, and the relative delay
to pupariation is normalized to that of the appropriate control, which
has been set at 0. In this figure CS-A larval treatment groups are
represented using circles and OR larval treatment groups by diamonds.
The size of each data point is scaled to the inoculation dose (highest
dose/largest circle is 2:9|109 cfu/plate; smallest dose/smallest circle is
2:9|102 cfu/plate; highest dose/largest diamond is 4:4|107; lowest
dose/smallest diamond is 1:8|104); Pf0-1 (blue), SBW25 (green), Pf-5
(red), killed Pf-5 (gray) and a Pf-5 gacA mutant (open red circle). (A) The
relative developmental delay (see Materials and Methods) during the
larval stage (X-axis) was plotted against the percentage of larvae that
survived to pupariate (Y-axis) for six different experiments. (B) The
relative developmental delay during the pupal stage (X-axis) was
plotted against the percentage of pupae that survived to adult
survivors (Y-axis). (C) The relative developmental delay during larval
and pupal stages (X-axis) was plotted against the percentage of larvae
that survived to adult (Y-axis).
doi:10.1371/journal.pone.0012504.g004
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attainment of a critical weight in the third instar larval stage in
response to hormonal signaling associated with the growth of the
imaginal discs, which generate the adult external structures
[19,20,21,22]. We measured the surface area of the wing blade
as a convenient indicator of body size to determine whether larval
developmental delay was correlated with changes in body size.
Wing surface area was inversely related to the dose of Pf-5 in the
diet (Fig. S2). At 10
7 cfu/plate, the treatment with the highest cell
density of Pf-5 compatible with survival to adulthood, the wing
surface area of surviving adults differed significantly from those of
control, Pf0-1, and SBW25 treatments, suggesting that the delay in
pupariation may be a compensatory mechanism: after exposure to
lower populations of Pf-5 cells, the delay allows larvae the time
needed to reach their critical weight and normal body size.
Pf-5 and SBW25 cause structural and behavioral defects
in adult flies
Larval ingestion of Pf-5 and SBW25 produced several larval and
adult phenotypes in addition to developmental delay and/or
lethality. Immediately after the control-,Pf0-1- or SBW25-infested
yeast suspensions were added to the assay plates, the larvae
remained in place or moved to the region of the plate where the
yeast was applied. In contrast, larvae responded to the Pf-5
inoculum by moving away from the site of application towards the
edges of the plate. For example, about half of the larvae (61618%)
moved to the side of the dish or wall within two hours of applying
a yeast suspension having 10
9 cfu of Pf-5 to the middle of the plate
(data not shown). Although we do not know the nature of the
repulsive agent in Pf-5, it was associated with high concentrations
of live cells of Pf-5. Larvae did not move away from yeast
suspensions having a high dose (10
9 cfu/plate) of killed Pf-5 cells or
a lower dose (#10
7 cfu/plate) of viable Pf-5 cells.
Because D. melanogaster larvae were found to cease feeding after
exposure to P. entomophila [7,23], we tested if they responded the
same way to strains Pf-5, SBW25, or Pf0-1. However, when larvae
were fed a bacterial suspension containing food dye, the dye was
found in the guts of some or most live larvae at one hour and for
up to one day, suggesting that larvae continued to feed after
exposure to these three P. fluorescens strains at the concentrations
that we tested (data not shown).
Larvae fed moderate to high concentrations of Pf-5
(2:9|104{109cfu/plate) had a very characteristic appearance
that differed from larvae fed control, Pf-5 gacA mutant or killed Pf-
5 treatments (Fig. 5A–F). After moderate to high Pf-5 treatments,
second and third instar larvae were lethargic and the lateral sheets
of fat body organ lost their opaque appearance. At death, the
larvae were nearly clear and lacked any visible fat body (Fig. 5F).
These third instar larvae remained very small and the main
tracheal trunks, which stretch dorsally along the full length of the
body, had a convoluted trajectory due to the failure of the larvae to
extend to full size (Fig. 5D–F). Control third instar larvae typically
dig into the agar of the plate in their search for food, whereas the
larvae ingesting high doses of Pf-5 (10
7–10
9) remained on the
surface of the plate.
We observed a striking physical difference in immune response
between larvae ingesting SBW25 compared to Pf-5. In the
Figure 5. Effects of P. fluorescens strains on the morphology of
third instar larvae. Third instar larvae on the surface of the treatment
plates were photographed using a digital camera mounted on a
dissecting scope. Bar is 1 mm with 0.1 mm divisions. (A) 96 hour post
control treatment. (B) 72 hour post Pf0-1 treatment (1:2|107 cfu/plate).
(C) 72 hour post Pf-5 gacA mutant treatment (2:2|107 cfu/plate). (D)
48 hour post Pf-5 treatment (1:6|107 cfu/plate), showing small body
size and convoluted longitudinal tracheal trunks. (E) 72 hour post Pf-5
treatment (1:6|107 cfu/plate), showing small body size and convoluted
tracheal trunks. (F) 72 hour post Pf-5 treatment (2:9|109 cfu/plate),
showing loss of fat body opacity and a melanotic nodule. (G) 72 hour
post SBW25 treatment (2.9610
7 cfu/plate), with no melanization within
the body cavity. (H) 72 hour post SBW25 treatment (5:2|109 cfu/plate)
showing melanization within the posterior third of the body. (I) 72 hour
post SBW25 treatment (5:2|109 cfu/plate) showing complete melani-
zation reaction.
doi:10.1371/journal.pone.0012504.g005
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larvae appeared similar to control larvae, whereas the subset of
larvae that died developed a systemic melanization reaction
followed by death (Fig. 5A, G–I). The first evidence of
melanization occurred in the middle of the third instar stage with
the appearance of black nodules and epidermal lesions. Subse-
quently, larvae developed widespread blackening within the body
cavity in the posterior abdomen near the malphigian tubules
(Fig. 5H). Over the course of the next 6–12 hours, melanization
spread throughout the entire body cavity and the animals died
swollen and fully extended (Fig. 5I). Larvae that did not develop a
melanization reaction successfully pupariated, but in the middle of
the pupal stage, about half of these pupae developed a systemic
melanization reaction and died. We also noted that many adult
flies died post-eclosion after a systemic melanization reaction
occurred. By contrast, the Pf-5-treated larvae had the occasional
small black nodules associated with tissues or black lesions in the
epidermis, but did not show the whole body melanization response
exhibited by a subset of larvae that ingested SBW25 (Fig. 5F). In
order to determine whether the ingestion of P. fluorescens strains
induced an immune response, we used a line of D. melanogaster
expressing b-galactosidase under the control of the promoter of an
immune challenge inducible gene encoding an antimicrobial
peptide, diptericin-lacZ. Second instar larvae were fed Pf0-1, Pf-5
and SBW25 and then dissected as feeding or wandering third
instar larvae for b-galactosidase activity. We found that third instar
larvae exposed to all three bacterial strains or the Pf-5 gacA mutant
expressed b-galactosidase in their gut and fat body suggesting that
their immune system had been activated (Fig. S3).
The adult survivors of Pf-5 and SBW25 treatments showed
morphological defects in specific external structures (Fig. 6, Table
S1). In pilot experiments, flattened cuticle preparations of adult
survivors of bacterially treated larvae were examined and eyes,
head capsule, legs and wings were the only structures in which
defects were detected (data not shown). The most common defects
in the eye were an abnormally small size and/or the presence of
anterior and posterior nicks at the equator, sometimes accompa-
nied by small duplications of bristles and head capsule epidermis
(Fig. 6A). A few flies from the Pf0-1-treatment groups had small
eye phenotypes but, by Chi-squared analysis, the frequency was
Figure 6. Morphological defects in adult survivors after infection with Pf-5. (A) Eye images from control and bacterial treatment groups.
Top panel from left to right: control; 5:7|109 cfu/plate, Pf0-1; 1:9|107cfu/plate Pf-5 gacA mutant; 2:9|109 cfu/plate killed Pf-5. Bottom panel from
left to right: 2:9|102 cfu/plate Pf-5; 1:9|107 cfu/plate Pf-5; 1:9|107cfu/plate Pf-5; 5:2|109 cfu/plate SBW25. Magnification bar=500 mm. (B) Images
of wing blades from adult flies after control (upper left) or Pf-5 at 2:9|102 cfu/plate (bottom left, right panel) treatments. Developmental defects
visible in these wings include loss of cells at the distal margin (upper right) and/or the presence of ectopic wing veins (bottom left and right).
Magnification bar=100 mm.
doi:10.1371/journal.pone.0012504.g006
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treatment group (4%, X
2=1.09, Df=3, P=0.78). Treatment with
any dose of live Pf-5 bacteria caused the majority of the surviving
flies to have an eye phenotype that was significantly different from
that of the control (91%, X
2=245.78, Df=7, P,0.00001). Similar
eye defects were found in survivors of Pf-5 treatment of larvae
from the OR or the two other CS strains (Fig. S4). At low to
moderate doses of Pf-5, we observed wing defects, such as the
presence of extra wing veins and loss of small portions of the wing
margin (Fig. 6B), however the average frequency of wing defects
spanning all tested doses was not significant (12%, X
2=6.50,
Df=7, P=0.37). On rare occasions, we saw defects in the leg
joints but there was no consistent pattern (1%, X
2=0.09, Df=7,
P=0.99). Somewhat surprisingly, unlike the frequency of survival
or developmental delay, the frequency of eye and wing defects in
Pf-5 treated animals did not show an obvious dose-response
relationship. Flies that developed after treatment with Pf-5 gacA
mutant or heat-killed cells had fewer defects than those treated
with live Pf-5 cells (6%, X
2=0.77, Df=2, P=0.95; 23%,
X
2=3.40 [n=1 inoculation dose]; respectively), suggesting that
these phenotypes may be a consequence of GacA function. Only
the highest dose of SBW25 had a small eye phenotype (87%,
X
2=17.30, [n=1 inoculation dose]), suggesting that a differential
affect on adult survival and morphology by the three P. fluorescens
strains accompanies the previously demonstrated distinct survival
and developmental delay phenotypes.
Colonization of D. melanogaster larvae by P. fluorescens
Because of the dose- and strain-dependent effects of P. fluorescens
on D. melanogaster survival and development, the population sizes of
the three strains were assessed from surface-sterilized larvae
(Fig. 7). All three strains increased to an internal population size of
10
2 to 10
5cfu/larva over the course of the experiment. The
population size of Pf-5 bacteria generally exceeded those of
SBW25 or Pf0-1. In a second experiment, population sizes of the
gacA mutant were compared to those of Pf-5 and found to be
similar. Therefore, the three strains of P. fluorescens colonized
internal tissues (including the gut cavity) of the larvae and, at least
for strain Pf-5, the capacity to establish internal populations was
independent of gacA.
Discussion
In nature, D. melanogaster live in an environment full of
microorganisms, yet only a few microbes are known to be lethal
to wild-type D. melanogaster larvae and/or adults, including
Pseudomonas aeruginosa, Pseudomonas entomophila, Serratia marcescens
and Beauveria bassiana ([7,8,24,25]. Here, we demonstrate that the
insecticidal activity of P. fluorescens strain Pf-5, which was observed
previously after injection of the tobacco hornworm Manduca sexta
and the greater wax moth Galleria mellonella [10], is also exhibited
when Pf-5 is introduced into D. melanogaster through a more natural
route including direct contact and feeding of larvae. Strain SBW25
Figure 7. Population sizes of P. fluorescens in larvae of D. melanogaster. Second instar larvae were inoculated with strains Pf0-1 (blue), SBW25
(green), or Pf-5 (red) (A and B), or the Pf-5 gacA mutant (open circle) or wildtype Pf-5 (filled circle) (C and D). Each day following inoculation, larvae
were individually surface sterilized, homogenized and bacterial numbers were estimated by culturing. Each point represents the average of five
larvae. Bacterial population sizes in the inocula were 10
4 cfu/plate (A and C), or 10
7 cfu/plate (B and D). The dotted line denotes the limit of detection.
On Day 4, larvae inoculated with Pf0-1 at 10
7 cfu/plate had pupariated and were not sampled. Error bars denote standard errors.
doi:10.1371/journal.pone.0012504.g007
Bacterial Induced Larval Death
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12504also caused lethality at both feeding and non-feeding stages, but to
a lesser extent than Pf-5. As reported previously [26], insect
lethality is not universal to P. fluorescens strains, and strain Pf0-1
exhibited no detectable toxicity to larvae after ingestion.
Nevertheless, ingestion of Pf0-1, like Pf-5 and SBW25, induced
an immune response in larvae, assessed using a transgenic line of
D. melanogaster containing a diptericin-lacZ reporter gene fusion.
Diptericin plays a critical role in defense of Drosophila against
Gram-negative bacteria, including P. entomophila [23], being one of
the anti-microbial peptides regulated by the Imd immune response
pathway. Therefore, as all three strains of P. fluorescens were able to
induce Diptericin gene expression, the difference in their toxicities
may reflect their differential capacities to overcome or thwart
different aspects of the immune response of Drosophila. The
results of this study place P. fluorescens strains Pf-5 and SBW25 in a
small group of bacteria that cause mortality of D. melanogaster larvae
through feeding or physical contact.
Ingestion of either P. fluorescens Pf-5 or SBW25 was lethal to
larval D. melanogaster from two different wild-type strains, but the
bacterial strains caused markedly different, dose-dependent host
responses. When high doses of Pf-5 were ingested, nearly all larvae
died and most failed to molt to the third instar stage. This response
is similar to that reported previously for P. entomophila: 70% of wild-
type third instar larvae died after ingestion of high doses of P.
entomophila [7]. In the present study, dose-response relationships
were also explored, and developmental delay was the most striking
consequence of ingestion of lower, sub-lethal doses of Pf-5.
Although larvae exposed to sub-lethal doses of Pf-5 pupariated,
many of these pupae later died, indicating that the consequences
of bacterial ingestion extended into non-feeding stages. In
addition, the marked delay in metamorphosis was accompanied
by phenotypic changes, such as reduced larval body size and loss
of fat body integrity. One of these phenotypes, small larval body
size, is also a consequence of ingestion of P. entomophila [7].
Occasionally, Pf-5-treated larvae also exhibited a few small
melanized nodules, a reaction that is unlikely to be sufficient to
cause death. Very rarely, Pf-5-treated larvae turned light brown,
but the color change appeared to be post-mortem. In contrast, a
striking systemic melanization throughout the hemolymph typi-
cally preceded death for the subset of larvae that died following
ingestion of strain SBW25. This melanization response is
considered to be symptomatic of an overactive immune system,
which can be lethal [2]. Correspondingly, in the present study, all
larvae or pupae that exhibited systemic melanization later died.
Those larvae that did not develop the systemic melanization
appeared to develop into pupae at normal rates, indicating that
SBW25 did not cause the developmental delay associated with
sub-lethal doses of Pf-5.
Many of the developmental and morphological phenotypes
associated with Pf-5 ingestion by larvae, including small body size,
loss of fat body integrity and prolonged larval development, are
reminiscent of larval responses to starvation. During the feeding
stages, larvae grow by increasing the size of terminally differen-
tiated polyploid cells in larval tissues, and the adult precursor cells
in the imaginal disc undergo numerous divisions. Attainment of
normal larval body size has been shown to require continuous
acquisition of dietary protein, whereas the continued division of
imaginal disc cells is largely independent of nutrition; instead,
these cells require circulating growth factors, which are produced
by fat bodies [27]. Early in the third instar, larvae assess their
critical weight, a checkpoint used to determine the timing at which
to initiate metamorphosis [21]. If starved before the critical weight
assessment, larvae delay the onset of metamorphosis, whereas
larvae starved after this checkpoint metamorphose early and at a
smaller size [19,20]. Wild-type larvae starved from hatching, by
feeding only with sucrose, survive for up to a week [28]. Therefore,
the three-day delay in metamorphosis and reduced larval body size
observed in this study are consistent with a starvation response of
larvae at early stages of development prior to the assessment of
larval critical weight. Vodovar et al. [7] and Liehl et al. [23]
observed that oral infection with P. entomophila caused a cessation
in food uptake by third instar larvae of D. melanogaster. In our
experiments, larvae were provided with sufficient nutrition to
complete development and appeared to continue to feed.
Therefore, we propose that ingestion of Pf-5 may block larvae
from feeding or impair their ability to use or obtain the necessary
nutrition to maintain their growth and development. An
interesting, although as yet untested, possibility is that Pf-5
ingestion may alter the activity of molecular regulators of larval
cell growth and nutrition, such as the insulin receptor/phosphi-
nositol kinase signaling and the TOR (target of rapamycin)
pathway, which are known to phenocopy starvation in fed larvae
[28,29,30]. Alternatively, a delay in morphogenesis can also result
from damage to the developing imaginal discs, which regulate
critical size in Drosophila [20,22], and larvae fed the highest doses
of Pf-5 compatible with survival produced smaller adult flies as
evidenced by atypically small wings. These results suggest that at
least some of the delay in metamorphosis may be due to damage
or slower cell divisions of the imaginal disc cells in response to Pf-5
infection.
Ingestion of Pf-5 or SBW25 caused specific morphological
defects in two different strains of wild-type adult survivors. The
defects in the eye, leg and wing discs are similar to those found in
adults with mutations in certain genes, such as cut, or mutations
that disrupt hormonal signaling necessary for initiating pattern
formation of the imaginal discs (e.g. [31]). The similarity between
the eye and wing phenotypes suggest that ectopic apoptosis of cells
within the imaginal discs result in the absence of ommatidia in the
eye and loss of wing margin cells in larvae ingesting Pf-5 or
SBW25. It is possible that modulation of or interference with the
host’s immune system by microbial factors could lead to the
morphological defects found in Pf-5- and SBW25-treated
survivors. For example, peptidoglycan-recognition proteins have
been shown to activate the D. melanogaster immune system through
NF-kB-like factors that can substitute for one another in the
developing animal [4,32]. Furthermore, RNAi experiments of
PGRP-SC1/2 in infected D. melanogaster larvae led to increased
developmental defects, including wing margin defects and lethality
[33]. Alternatively, it is possible that bacterial factors interact with
other non-immune-related developmental pathways to create the
morphological defects we observe.
The three strains of P. fluorescens evaluated in this study caused
remarkably different host responses when fed to second instar D.
melanogaster larvae. This observation is not surprising given the
enormous genomic diversity of the strains, which share only ca.
60% of their proteomes [13,34]. Furthermore, strain variation in
virulence to D. melanogaster is well recognized in P. aeruginosa [35], a
genus that is far more homogenous than P. fluorescens as presently
defined [13,36]. An obvious reason for the differential effects of the
P. fluorescens strains on the insect is the distinctive genetic
compositions of these bacteria. The genomes of Pf-5 and
SBW25 each contain ca. 1500–1600 genes that are lineage-
specific, having no defined orthologs in the genomes of either the
other strain or Pf0-1 [13,34]. Certain of these lineage-specific
genes may have direct roles in the lethality and developmental
delay observed in Drosophila following bacteria ingestion. For
example, genes for the biosynthesis of at least eight secondary
metabolites toxic to certain eukaryotes are among the products of
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lineage-specific genes in the SBW25 genome are those encoding a
type III secretion system [37], an export pathway found in many
Gram-negative bacteria that injects bacterial effectors into the
cytosol of eukaryotic cells [38]. The type III secretion apparatus
and effectors are key factors in the pathogenicity of P. aeruginosa to
D. melanogaster [39,40], but this machinery is lacking in P. fluorescens
strains Pf-5 and Pf0-1 and P. entomophila [12,41]. A key role of
Type III secretion is in overcoming host defense response [42,43],
although these pathways represent only one mechanism that
bacteria can employ to silence the host immune system, thereby
allowing them to invade and colonize the animal. In this study, we
found that all three strains of P. fluorescens, including the relatively
benign strain Pf0-1, became established in the gut cavity or
internal tissues of Drosophila larvae and induced host expression
of the gene encoding the antimicrobial peptide, Diptericin.
Internal population sizes of the lethal strain Pf-5 were higher
than those of the other two strains, which could reflect an
enhanced capacity to suppress host immune responses, the
expanded availability of nutritional substrates as a consequence
of host cellular breakdown, or other factors. In P. aeruginosa,
pathogenicity is mutifactorial, with many bacterial genes contrib-
uting to mortality of Drosophila [44]; and combinatorial, with
distinct sets of genes required for pathogenicity of different strains
[45]. Similar levels of complexity are likely to operate in P.
fluorescens, and differences in gene regulation as well as composition
among the three strains could contribute to their varied effects on
host response.
A gacA mutant of P. fluorescens strain Pf-5 exhibited attenuated
toxicity against D. melanogaster, but GacA was not required for
colonization of internal tissues of the larvae. gacA mutants of P.
aeruginosa [44] and P. entomophila [23] also display reduced toxicity
against D. melanogaster. The GacS/GacA signal transduction system
is highly conserved among Pseudomonas spp., acting via the positive
control of regulatory RNAs to serve as a master regulator of genes
encoding for diverse cellular functions, including chronic and
acute infection. In P. fluorescens Pf-5, the GacS/GacA system
controls multiple phenotypes, including secondary metabolite and
exoenzyme production, stress response, and motility
[15,16,17,46]. Furthermore, a recent transcriptomic analysis
identified more than 600 genes expressed under the control of
GacA, further highlighting the central role of the GacS/GacA pair
in cellular function of the bacterium [16]. Among the genes
positively controlled by GacA are those with demonstrated roles in
Drosophila lethality of other Pseudomonas spp. Examples include
aprA, which encodes an extracellular metalloprotease that
contributes to oral toxicity of P. entomophila [23] and hcnA, involved
in the biosynthesis of hydrogen cyanide, one of many factors
contributing to the injectable lethality of P. aeruginosa [44,47]. The
GacA regulon of Pf-5 includes many other secondary metabolites,
toxins, secretory systems, and exoenzymes that could contribute to
the gacA-regulated lethality and developmental delay observed
herein. Identification of the specific genes and phenotypes
functioning in the newly-recognized ingestible toxicity of Pf-5
represents a promising avenue for inquiry that is likely to reveal
novel factors functioning in host-microbe interactions.
The most striking finding of this study is the observed link
between the physiological response to microbial infection and
alterations in the growth, development and differentiation of D.
melanogaster larvae and adults. A second significant finding is the
identification of two strains of P. fluorescens that cause mortality of
wild-type D. melanogaster when ingested. While other groups have
focused on the immune response of larvae or adult flies to bacterial
infection, we characterized the effects of larval infection on the
animals throughout development, thereby identifying novel host
responses to bacterial infection. A new non-invasive feeding
protocol that mimicked natural routes of microbial infection,
which was developed in this study, was key in establishing a link
between microbial infection and developmental delay in the P.
fluorescens-Drosophila interaction. Our study demonstrates strain-
specific effects of P. fluorescens on D. melanogaster morphogenesis and
mortality, and opens the door to further investigation into strain-
specific and GacA-mediated mechanisms of pathogenicity in a
new model system. The combination of complete genomic
sequence data, genetic tractability, and sophisticated analytical
tools for D. melanogaster and P. fluorescens will facilitate future
characterization of the cellular, molecular and developmental
components of the host-microbe interactions observed in this
study.
Materials and Methods
Bacterial strains and culture conditions
Three strains of Pseudomonas fluorescens having fully sequenced
genomes were evaluated: strain Pf-5 was isolated from soil in
Texas, USA [48]; strain SBW25 was isolated from the phyllo-
sphere of sugar beet in Oxfordshire, England [49]; and strain Pf0-
1 was isolated from an agricultural soil in the USA [50]. Cultures
of SBW25 and Pf0-1 were obtained from Joseph Raaijmakers,
Wageningen University, and Mark Silby, Tufts University. A Pf-5
gacA mutant (JL4577) was constructed previously by replacing
626 bp (nt 1 to 626) internal to gacA with aphI, which confers
kanamycin resistance [16]. Inoculum for larval feeding experi-
ments was obtained by culturing strains of P. fluorescens on King’s
Medium B (KMB) [51] and incubating plates overnight at 27uC.
Strains were then inoculated into culture tubes containing 5 ml of
KMB broth and incubated with shaking (200 rpm) overnight prior
to harvest by centrifugation. Cells were washed once, resuspended
in sterile deionized water and diluted to an appropriate OD600 for
each experiment. The initial number of colony forming units (cfu)
for each experiment was determined by spreading samples from
serial dilutions on KMB.
Drosophila melanogaster cultures
Four isogenic wild-type lines of D. melanogaster were used: A
CantonS-A (CS-A) line of D. melanogaster, obtained from Jeffrey C.
Hall, Brandeis University; a Canton-S (CS) line obtained from
William W. Mattox, MD Anderson Cancer Center; a Canton-S
(CS) line from Jadwiga Giebultowicz, Oregon State University;
and an Oregon-R (OR) line from Chris Q. Doe, University of
Oregon. All Drosophila lines were maintained at 25uC, in a 12 hour
light and 12 hour dark cycle (12L:12D), on standard cornmeal,
dextrose, yeast and agar media with Nipagin (p-hydroxybenzoic
acid methyl ester, Sigma Aldrich, Inc., St. Louis, MO, USA). A fly
line containing a diptericin-lacZ fusion with isogenic CS-A second
and third chromosomes, y, w, DDI;+;+ [52] was employed in
experiments evaluating the capacity of P. fluorescens to trigger an
immune response involving activation of the antimicrobial peptide
Diptericin by detection of b-galactosidase activity using standard
methods.
Non-invasive insect toxicity assay
To test the toxicity of P. fluorescens strains to D. melanogaster,w e
developed a non-invasive assay (Fig. 1), which required transfer-
ring insects only at the egg stage, thereby minimizing the risk of
stress or wounding prior to infection. To reduce fungal and
bacterial contamination, all experiments were performed using
autoclaved medium, sterile plates, pipettes, microcentrifuge tubes
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adults were prepared from yeast (Fleischmann’s Active Dry yeast,
Fenton, MO, USA) microwaved 2–3 times for 30 seconds to kill
the yeast cells. To obtain eggs, females were collected as virgins,
mated with males for 4–6 days in standard food vials, and then
transferred to egg-laying chambers with apple juice agar plates
prepared without Nipagin (Apple agar).
The experimental design is outlined in Figure 1. On the first day
of the experiment (Day 22), flies were transferred to Petri plates
containing Apple agar supplemented by yeast grains (20 mg), and
plates were incubated for four hours at 25uC to allow egg lay.
From these plates, thirty eggs were transferred aseptically to the
surface of non-nutritive agar (2% wt/vol agar in water) having 2–
3 mg yeast grains distributed on the agar surface in a 35 mm Petri
plate. Plates were incubated at 25uC. The number of first instar
larvae per plate was determined on Days 21 and 0 by counting
the number of empty egg cases. On Day 0, 200 ml of a yeast
suspension was added to the middle of the plate to serve as a food
source for second instar larvae. The yeast suspension was prepared
by dissolving 0.2 g yeast in 1.2 ml of sterile water or a bacterial
suspension, prepared as described above. The plates were
transferred to 22uC and, starting at Day 2, larvae were fed with
100 ml of a yeast suspension (0.2 mg yeast/1.2 ml sterile water) at
48 hour intervals as long as live larvae were observed in the dish.
Three replica plates were established for every treatment group in
the development and survival experiments. The developmental
stage was determined at 24-hour intervals and the number of
pupae counted until adult emergence. Adult flies were anesthe-
tized with CO2 and then fixed in alcohol. Larval development was
documented through images captured by a digital camera
mounted on a dissecting scope with images adjusted only for
contrast and brightness in Photoshop (Adobe Systems Inc., San
Jose, CA, USA) as needed.
We established that the assay procedures were sufficient for D.
melanogaster larval survival and development by assessing the
proportion of CS-A eggs that survived in control treatments. In
these control plates, 9260.5% of the eggs transferred to the assay
plates (n=6,928 eggs on 231 plates in seven experiments) hatched
into first instar larvae and 8664% of the larvae survived to
adulthood. This level of adult survival is consistent with a null
hypothesis expectation of 100% survival to adulthood for larvae in
our control treatment regimen by Chi-squared analysis (X
2=3.57,
Df=6, P=0.73359). Based upon this statistical analysis, the
procedures for rearing flies were shown to provide an experimen-
tal system for assessing the consequence of natural infection of
larvae of D. melanogaster without introducing artifacts or stress
associated with transfer or manipulation of the insect beyond the
egg stage of development.
Calculation of the duration of developmental stages
Because some bacterial treatments lengthened the duration of
insect development, we quantified the developmental delay as
follows. First, for each experiment, the duration of larval
development post-inoculation was empirically determined as the
interval (hours) between inoculation and the time when pupariation
hadreached 50%of the totalnumberofpupaeforthecontrolgroup
(T1/2 pupae control), based on repeated counts of pupae and prepupae
over the course of the experiment (as in Figs 2 and 3). Second, for
each treatment group in a given experiment, the duration of larval
development was determined as the interval between inoculation
and the time when pupariation had reached 50% of the total
number of pupae for each treatment (T1/2 pupae treatment). For within
and between experiment comparisons, the difference between the
duration of the larval stage for a bacterial treatment and the
duration of the larval stage for control larvae was calculated as
T1=2 pupae treatment{T1=2 pupae control

=24 hours/day. Similarly, for
each experiment we determined the duration of pupal development
as the interval between T1/2 pupae control, and the time when 50% of
flies had emerged from the pupal case (T1/2 adult control). The
difference between the duration of pupal development for each
treatment group and the duration of the pupal stage for control
pupae was calculated as T1=2 adult treatment{T1=2 pupae treatment

{

T1=2 adult control{T1=2 adult pupae

=24 hours/day. The difference in
the duration of both larval and pupal stages for each treatment
group was calculated as T1=2 adult treatment{T1=2 adult control

=24
hours/day.
Bacterial colonization of larvae
Population sizes of the P. fluorescens strains internal to larvae of
D. melanogaster were estimated from surface-sterilized larvae. Six
larvae were placed in a drop of the sterilizing solution (2.5 ml
bleach and 45 ml 0.01% Triton-X in 10 ml water) for 60 seconds
and then transferred serially through four drops of sterile water
before being gently blotted and placed individually into a 1.5 ml
microcentrifuge tube. Each larva was then homogenized in 50 ml
of sterile distilled water, serially diluted, and the dilutions were
spread on KMB. Plates were incubated overnight at 27uC prior to
counting colonies. The experiment was done twice with similar
results, and results from one experiment are presented.
Morphological defect analysis
All adults that emerged were fixed in ethanol and then
examined through a dissecting scope for defects in their external
structures. In pilot experiments, flattened adult cuticle prepara-
tions were made by macerating the flies in hot 10% KOH solution
and placing in a mounting medium (Permount
TM, Fisher Scientific
Research, Pittsburgh PA). These adults were examined for
external morphological defects. We discovered morphological
defects in eyes, wings and legs. For subsequent experiments, flies
that had been fixed in ethanol were examined under a dissecting
scope and scored for defects in these structures. Eye defects
included smaller eye size and nicks at the edge of the equator.
Wing defects included extra or abnormal veins and loss of wing
margin cells. Abnormal leg joints were observed in some adults.
Digital images of eyes were captured directly into a camera
mounted onto a dissecting scope. Final images were only adjusted
slightly for contrast and brightness.
Wing size was used as a criterion to estimate adult body size.
From each adult fly, one wing was removed and mounted on a
slide in glycerol. Images of each wing were captured at 46 and
106 magnification using an Olympus Vanox A2 research grade
microscope with a digital camera. Photoshop images were
imported into Image Pro 4000 (Media Cybernetics, Bethesda,
MD, USA) for surface area measurements. The average wing
blade surface area was determined for 10 adult flies from each
treatment (except for treatments having low survival rates resulting
in less than 10 surviving adults). To evaluate the statistical
significance of treatment effects a one-way ANOVA was
calculated with the Tukey test for contrast (a=0.05; P,0.001;
F=7.64) using SigmaStat (Systat Software, Inc.).
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0012504.s001 (0.04 MB
DOC)
Figure S1 Adult survival after bacterial treatment. Adult survival
for each treatment group (circles represent CS-A and diamonds
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treatment group, the adult survival is normalized to the survival of
the appropriate control, which has been set at 100%. Each point is
scaled according to the dose (cfu/plate) for each bacterial
treatment. The size of each data point is scaled to the inoculation
dose (highest dose/largest circle=2.9610
9 cfu/plate; smallest
dose/smallest circle=2.9610
2 cfu/plate; highest dose/largest
diamond=4.4610
7; lowest dose/smallest diamond=1.8610
4);
Pf0-1 (blue), SBW25 (green), Pf-5 (red), killed Pf-5 (gray) and a
gacA mutant of Pf-5 (open red circle).
Found at: doi:10.1371/journal.pone.0012504.s002 (0.10 MB TIF)
Figure S2 Average wing blade surface area for adult survivors.
Lanes (1) control, (2) 5.7610
9 cfu/plate Pf0-1, (3) 5.2610
9 cfu/
plate SBW25, (4) 2.9610
9 cfu/plate killed Pf-5, (5) 2.9610
2 cfu/
plate Pf-5, (6) 2.9610
4 cfu/plate Pf-5, 7) 2.9610
5 cfu/plate Pf-5,
(8) 2.9610
7 cfu/plate Pf-5. Asterisk indicates significant difference
in wing-surface area from the control. See Materials and Methods
for details and calculations.
Found at: doi:10.1371/journal.pone.0012504.s003 (0.14 MB TIF)
Figure S3 Diptericin-lacZ expression in third instar larvae from
control and bacterial treatments. Fat body cells from third instar
y,w DDI larvae, which were dissected open and then stained for b-
galactosidase activity.(A) Segment of larval fat body (delimited by
arrows), positioned over body wall musculature, from a control
larva in which only a few cells express faint b-galactosidase
activity. (B) Labeled fat body cells, positioned over body wall
musculature, from a larva fed Pf0-1 at 10
7 cfu/plate.(C) Isolated
segment of larval fat body from a larva fed SBW25 at 10
7 cfu/
plate. (D) Isolated segment of larval fat body from a larva fed Pf-5
at 10
7 cfu/plate. (E) Isolated segment of larval fat body from a
larva fed gacA mutant Pf-5 at 10
7 cfu/plate.
Found at: doi:10.1371/journal.pone.0012504.s004 (3.65 MB TIF)
Figure S4 Morphological defects in adult survivors of Pf-5
treated OR and CS adults. Whole mount eye images from OR
adult (left panel) inoculated with 4.5610
4 cfu/plate Pf-5 and CS
adults (middle and right panels) inoculated with 1.7610
4 cfu/plate
Pf-5. The center of the eye in the right panel was damaged during
handling.
Found at: doi:10.1371/journal.pone.0012504.s005 (0.80 MB TIF)
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